Editorial

November 30, 2024


Editorial for JUO 2024 Vol. 22 No. 3 - Rethinking Urologic Oncology Surgery
Cheol Kwak
J Urol Oncol. 2024;22(3):185-187.

Original Article

November 30, 2024


Early Experience of the Single-Port Robotic Transvesical Radical Prostatectomy: Case Series
Jae Hoon Chung, Hwanik Kim, Woo Jin Bang, et al.
J Urol Oncol. 2024;22(3):188-195.

Original Article

November 30, 2024


Simultaneous Prostate Target Biopsy Integrated With Radical Prostatectomy: A Pilot Study Omitting Preoperative Systematic Biopsy
Tae Young Park, Jae Young Hwang, Seong Woo Yun, et al.
J Urol Oncol. 2024;22(3):196-200.

Original Article

November 30, 2024


A Machine Learning Model for Prostate Cancer Prediction in Korean Men
Sukjung Choi, Beomgi So, Shane Oh, et al.
J Urol Oncol. 2024;22(3):201-210.

Original Article

November 30, 2024


Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials
Matthew Rashid, Eli Oldham, Griffin K. Hughes, et al.
J Urol Oncol. 2024;22(3):211-223.

Brief Report

November 30, 2024


The Current Role of Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma
Hyung Joon Kim
J Urol Oncol. 2024;22(3):224-227.

Invited Review

November 30, 2024


Exploring the Evolving Role of Metastasectomy in Advanced Renal Cell Carcinoma
Jongkyou Kwon, Sungun Bang, Kang Su Cho
J Urol Oncol. 2024;22(3):228-236.

Original Article

November 30, 2024


Clinical Application of Artificial Intelligence-Based Computed Tomography Analysis of Myosteatosis in Localized Renal Cell Carcinoma
Byeong Jin Kang, Kyung Hwan Kim, Seung Baek Hong, et al.
J Urol Oncol. 2024;22(3):237-245.

Invited Review

November 30, 2024


The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer
Jong Ho Park, Jong Jin Oh
J Urol Oncol. 2024;22(3):246-255.

Invited Review

November 30, 2024


Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
Yongsoo Jo, Hyeong Dong Yuk
J Urol Oncol. 2024;22(3):256-267.

Review Article

November 30, 2024


Artificial Intelligence: The Latest Advances in the Diagnosis of Bladder Cancer
Satyendra Singh, Ram Mohan Shukla
J Urol Oncol. 2024;22(3):268-280.

Correction

September 11, 2024


Correction: Addendum of Informed Consent Statements
J Urol Oncol. 2024;22(3):281-281.

Expression of Concern

November 30, 2024


Expression of Concern: Rare Ewingoid Dedifferentiated Liposarcoma of the Spermatic Cord Causing Testicular Artery Compression: A Case Report
J Urol Oncol. 2024;22(3):282-282.
Editorial for JUO 2024 Vol. 22 No. 3 - Rethinking Urologic Oncology Surgery
Cheol Kwak
J Urol Oncol. 2024;22(3):185-187.

Editorial

Nov 30, 2024

Early Experience of the Single-Port Robotic Transvesical Radical Prostatectomy: Case Series
Jae Hoon Chung, Hwanik Kim, Woo Jin Bang, et al.
J Urol Oncol. 2024;22(3):188-195.

Original Article

Nov 30, 2024

Prostate Cancer
Simultaneous Prostate Target Biopsy Integrated With Radical Prostatectomy: A Pilot Study Omitting Preoperative Systematic Biopsy
Tae Young Park, Jae Young Hwang, Seong Woo Yun, et al.
J Urol Oncol. 2024;22(3):196-200.

Original Article

Nov 30, 2024

Prostate Cancer
A Machine Learning Model for Prostate Cancer Prediction in Korean Men
Sukjung Choi, Beomgi So, Shane Oh, et al.
J Urol Oncol. 2024;22(3):201-210.

Original Article

Nov 30, 2024

Prostate Cancer
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials
Matthew Rashid, Eli Oldham, Griffin K. Hughes, et al.
J Urol Oncol. 2024;22(3):211-223.

Original Article

Nov 30, 2024

Prostate Cancer
The Current Role of Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma
Hyung Joon Kim
J Urol Oncol. 2024;22(3):224-227.

Brief Report

Nov 30, 2024

Kidney Cancer
Exploring the Evolving Role of Metastasectomy in Advanced Renal Cell Carcinoma
Jongkyou Kwon, Sungun Bang, Kang Su Cho
J Urol Oncol. 2024;22(3):228-236.

Invited Review

Nov 30, 2024

Kidney Cancer
Clinical Application of Artificial Intelligence-Based Computed Tomography Analysis of Myosteatosis in Localized Renal Cell Carcinoma
Byeong Jin Kang, Kyung Hwan Kim, Seung Baek Hong, et al.
J Urol Oncol. 2024;22(3):237-245.

Original Article

Nov 30, 2024

Kidney Cancer
The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer
Jong Ho Park, Jong Jin Oh
J Urol Oncol. 2024;22(3):246-255.

Invited Review

Nov 30, 2024

Bladder Cancer
Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
Yongsoo Jo, Hyeong Dong Yuk
J Urol Oncol. 2024;22(3):256-267.

Invited Review

Nov 30, 2024

Bladder Cancer
Artificial Intelligence: The Latest Advances in the Diagnosis of Bladder Cancer
Satyendra Singh, Ram Mohan Shukla
J Urol Oncol. 2024;22(3):268-280.

Review Article

Nov 30, 2024

Bladder Cancer
Correction: Addendum of Informed Consent Statements
J Urol Oncol. 2024;22(3):281-281. Corrects: 2022;20(1):59 Corrects: 2022;20(2):133

Correction

Sep 11, 2024

Expression of Concern: Rare Ewingoid Dedifferentiated Liposarcoma of the Spermatic Cord Causing Testicular Artery Compression: A Case Report
J Urol Oncol. 2024;22(3):282-282. Expression of concern: 2022;20(4):273

Expression of Concern

Nov 30, 2024

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043


Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com

Copyright © The Korean Urological Oncology Society.

Developed in M2PI